| ID | 2094 |
| No | 2094 |
| Brand Name | OMENIX 40 |
| Ingredients | OMEPRAZOLE SODIUM BP 44.6323 MG EQ. TO OMEPRAZOLE 40 MG |
| Dosage Form | POWDER FOR SOLUTION FOR INJECTION |
| Primary Packaging | VIAL |
| Storage | |
| Shelf Life | 2 YEARS |
| Pack Size | BOX OF 1 VIAL + 1 AMPOULE OF 10 ML WATER FOR INJECTIONON |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | HEARTBURN, ANY SYMPTOMS OF GERD, EROSIVE ESOPHAGITIS, GASTRIC ULCER, DUODENAL ULCER AND REDUCTION OF RISK OF UPPER GI BLEEDING IN CRITICALLY ILL PATIENTS, PRIMARILY FOR THE TREATMENT OF ZOLLINGER-ELLISON SYNDROME |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | STERILE, FREEZE-DRIED, WHITE TO OFF-WHITE POROUS CAKE OR POWDER FILLED IN COLORLESS GLASS VIAL.
THE RECONSTITUTED SOLUTION IS CLEAR, COLORLESS AND HAVING NO VISIBLE RESIDUE AS UNDISSOLVED MATTER
|
| Note | |
| License Owner | PALAMY PHARMA CO., LTD |
| Manufacturer | INCEPTA PHARMACEUTICALS LIMITED |
| Country | BANGLADESH |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 05 I 3321/09 |
| FDD Registration Date | 23/11/2023 |
| Expiry Date | 22/11/2026 |